The 2020 Ambulatory Surgery Center Market Report covers the industry-wide shift in surgical procedures from inpatient to outpatient setting.
During first the several months of COVID-19, 100% of ASCs stopped elective surgeries, 73% stopped semi-elective surgeries, and 33% stopped non-elective surgeries.
ASCs perform 41% of surgical procedures. By the mid-2020s ASCs are expected to perform 68% of orthopedic surgeries
Key Topics Covered:
Executive Summary
ASC Market Overview
Surgeries Shift To Outpatient Centers As Surgery Volumes Grow
More Surgeries Are Done At ASCs Than Any Other Setting
ASC Procedure Volumes Fall During COVID-19
ASC Procedures Delayed During COVID-19
ASCs Expected To Play Critical Role Post-COVID-19
Majority Of ASCs Operate With Single Specialty
Number Of ASC Total Joint Replacement Procedures Grow
ASCs Offer Lower Cost Alternative To HOPDs
Cataract Surgery Most Performed ASC Service
Cataract Removal Leads ASC Procedures By Total Charges
Total Knee Replacement And Cardiac Procedures Added to CMS Payable List In 2020
ASC Quality Reporting Metrics For 2020 And 2022
73% Of Hospital ASCs Operated As Physician Joint Ventures
Majority Of ASC Centers Are Independent
Lower Cost And Convenient Recovery Touted As Top ASC Advantages
New Technologies Are Biggest Challenge For Outpatient Care
ASC Physicians Play Key Role In Purchasing Decisions
GHX Reports $2.0 Billion In Treatment Center Sales Through Distribution In 2019
GHX Reports Treatment Center Sales By Segment
GHX Lists Outpatient Surgery Products Sold Through Distribution
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global cell counting market was valued at US$9.98...
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....